Patient Guide: A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 4 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05547061
Status: ACTIVE_NOT_RECRUITING
Condition: Prostate Cancer, mCRPC
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 4 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Hwasun,
  • Seoul,
  • Seoul,
  • • And 1 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily